Health-Related Quality of Life as a Prognostic Measure of Clinical Outcomes in Renal Cell Carcinoma: A Review of the CheckMate 025 Trial
Crossref DOI link: https://doi.org/10.1007/s40487-017-0042-6
Published Online: 2017-03-23
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Grimm, Marc-Oliver
Grünwald, Viktor
Funding for this research was provided by:
Bristol-Myers Squibb